-
Researchers design way to root out fake vaccines
Researchers at University of Oxford in England have created a first-of-its-kind method to distinguish between authentic and fake vaccines that have entered supply chains. -
Vizient's new, renewed customers in Q2
In the second quarter of 2024, Vizient signed new and extended contracts with 11 healthcare organizations, the company said Aug. 29. -
Cardinal Health opens its largest at-home distribution center
Every day, warehouse employees and robotic technology will ship about 8,000 packages to patients' homes from Cardinal Health's new distribution center in Greenville, S.C., the company said Aug. 28. -
FDA clears 1st automated device for Type 2 diabetes
The FDA has expanded the indications for Insulet SmartAdjust technology to include the management of Type 2 diabetes in people 18 and older. -
Cardinal Health to build distribution center in Ohio
Cardinal Health is replacing its distribution center in Solon, Ohio, with a 30% larger facility in a nearby city. -
Inari Medical updates clot removal device instructions after 6 deaths
Inari Medical has updated use instructions for its ClotTriever XL catheter after four injuries and six deaths were reported in association with the device. -
After Canada's 2 largest railroads shut down, is the US medical supply chain affected?
The U.S. supply chain could see slight disruptions after a shutdown at Canada's two biggest rail networks, experts told Becker's. -
Defibtech recalls chest compression device
Defibtech is recalling its RMU-2000 ARM XR Chest Compression Device. -
FDA to create medical device surveillance program
The FDA is building a postmarket surveillance program for medical devices. -
Medline wins supply chain resiliency award
Medline is the first supplier to win the Healthcare Industry Resilience Collaborative's diamond-level resiliency badge for manufacturing, an award that more than 40 health systems recognize. -
J&J to buy heart failure devicemaker
Johnson & Johnson plans to scoop V-Wave, a heart failure devicemaker, for up to $1.7 billion by the end of 2024. -
Former FDA medical device director's industry ties scrutinized: New York Times
Jeffrey Shuren, MD, retired as director of the FDA's medical device division in July. Now, his ties to the industry are being questioned. -
Premier to gain 54 hospitals in new partnership
AllSpire Health GPO, a regional group purchasing organization based in Pennsylvania, selected Premier to support its annual $3.5 billion purchasing volume, the companies announced Aug. 20. -
The cost of shortages for hospitals: Premier
For the average health system with five hospitals or 650 beds, supply shortages increase the cost of care to $3.5 million, restrict up to $1 million in excess inventory and cause $350,000 in lost revenue, according to Premier. -
CMS: Blood culture bottle shortage may affect quality measures
CMS has issued a statement to healthcare providers regarding the ongoing BD BACTEC blood culture media shortage, which is expected to continue late into the year. -
FDA clears Big Health's digital insomnia therapeutic
Big Health has secured FDA clearance for its flagship digital therapeutic, SleepioRx, as an adjunct treatment for chronic insomnia. -
5 Medline partnerships
So far in 2024, Medline has secured five agreements with health systems, including new agreements and additional deals to ongoing partnerships. -
107 adverse events tied to insulin pump app: FDA
Patients who use an insulin pump's mobile app are reporting software issues with the app's former and current versions, the FDA said Aug. 12. -
A whole new supply chain
After the COVID-19 pandemic yanked the global supply chain's norms and expectations, the industry mutated, The New York Times reported Aug. 12. -
Medical devicemakers critique CMS ruling
CMS decided Aug. 8 to expedite coverage for up to five medical technologies every year, and the final ruling is drawing flak from the Medical Device Manufacturers Association.
Page 5 of 50